Absci prices $50M public offering of 16.67M shares at $3.00 per share

Absci Corp

Offering of 16,670,000 shares at $3.00 per share; gross proceeds ~$50M.
Net proceeds estimated at ~$46.7M (or ~$53.7M if underwriters' option exercised in full).
Proceeds to fund internal programs, Integrated Drug Creation platform, and general corporate purposes.
Underwriters: Morgan Stanley, J.P. Morgan, Jefferies, TD Securities; expected close July 28, 2025.
Offer made under effective shelf registration statement on Form S-3 (File No. 333-267043).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.